UK markets closed

Royalty Pharma PLC (RPD.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
26.31+0.12 (+0.46%)
At close: 08:08PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,238,561
2,354,554
2,237,215
2,289,463
2,122,353
Operating expenses
Research development
52,000
52,000
177,106
200,084
26,289
Selling general and administrative
221,705
249,748
227,303
182,826
181,715
Total operating expenses
1,299,157
862,404
1,314,323
858,748
461,901
Operating income or loss
939,404
1,492,150
922,892
1,430,715
1,660,452
Interest expense
184,469
187,187
187,961
166,142
157,059
Total other income/expenses net
368,785
322,834
-583,202
-76,907
170,182
Income before tax
1,186,726
1,700,088
230,064
1,241,201
1,701,954
Income tax expense
0
0
0
0
0
Income from continuing operations
1,186,726
1,700,088
230,064
1,241,201
1,701,954
Net income
798,857
1,134,834
42,832
619,728
975,040
Net income available to common shareholders
1,191,583
1,527,560
42,832
619,728
495,198
Basic EPS
0.39
-
0.10
1.49
2.51
Diluted EPS
0.39
-
0.10
1.49
2.51
Basic average shares
446,678
-
437,963
414,794
388,135
Diluted average shares
446,678
-
437,972
414,802
388,135